Skip to main content

Table 5 Univariate analysis of the patients’ outcome according to the Aspergillus species and antifungal treatment

From: In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia

 

Death

Survival

P

Aspergillus section Flavi

6 (33%)

12 (40%)

0.81

Aspergillus section Nigri

10 (56%)

16 (53%)

Other Aspergillus spp.

2 (11%)

2 (11%)

Treatment

AMB

7 (39%)

3 (10%)

0.02

VOR

2 (11%)

12 (40%)

 

No

9 (50%)

15 (50%)